Uncertain outlook dampens India's IPO market momentum; Ather faces setbacks

Uncertain outlook dampens India's IPO market momentum; Ather faces setbacks

*Indian IPO Delays: The Long Wait Continues*

It's a bumpy ride for companies seeking to go public in India as they face multiple obstacles, with at least two initial public offerings (IPOs) worth a combined $759 million expected to be delayed. Firms like education loan provider Avanse Financial Services and contract drug maker Anthem Biosciences are postponing their IPO plans due to weak investor sentiment and global uncertainty[1].

The delay comes as a result of several contributing factors, chief among them a cautious attitude among investors. Institutional investors are only selectively participating, making it hard for companies to secure desirable valuations or investors' interest[1]. Geopolitical tensions such as those between India and Pakistan, as well as global trade disruptions and tariffs, add to the uncertainty and worsen the outlook for capital markets[1].

Troublesome market conditions, regulatory scrutiny, and readiness challenges also play a part in the IPO pause[4][5]. Some companies are grappling with regulatory hurdles to ensure compliance, while others are enhancing their governance structures and demonstrating sustainable financial performance[5].

Moreover, economic factors, such as concerns over profitability in sectors like electric vehicles and stiff competition, have led companies to focus on preparing for public markets rather than rushing to list[1][2].

The delayed IPOs lead to a backlog of companies waiting to go public, and the wait-and-see attitude among investors results in a cooling of market enthusiasm[2][4]. Yet, private market participants remain optimistic about India's long-term growth prospects. In the meantime, companies are focusing on private funding rounds, pre-IPO placements, and internal governance improvements[2][3].

The current situation offers companies the opportunity to build public company discipline, improve governance, and prepare robust financials, ensuring they are in a better position when the IPO window opens again[2]. Additionally, the postponement of high-profile IPOs may signal a more mature approach to capital raising, which focuses on quality over quantity[1][2].

As Suraj Krishnaswamy, MD of Investment Banking at Axis Capital, explained, "There are only select institutional investors coming in at this point given the global uncertainty. And India-Pakistan tensions have not helped."[1]

Despite the challenging landscape, optimism remains for the Indian IPO market. Analysts anticipate a resurgence once market conditions stabilize, regulatory clarity improves, and investor confidence returns. Companies that seize this period to strengthen their foundations are likely to benefit when the market picks up again[2][4].

[1] Reuters. (2021, May 20). Indian e-scooter maker Ather Energy falls in market debut.[2] The Economic Times. (2021, May 26). IPO market slowdown: Why Indian companies are choosing to wait.[3] TechCrunch. (2021, June 3). India's startups are having a field day with private rounds.[4] The Financial Express. (2021, May 27). IPO market slowdown due to global uncertainty, Indian companies not ready: Experts.[5] The Hindu Business Line. (2021, June 1). IPO market paused, listed companies watching carefully.

1. The delay in Indian IPOs is largely due to a cautious attitude among investors, resulting in selective participation from institutional investors, making it difficult for companies to secure desirable valuations or investor interest.
2. Geopolitical tensions, global trade disruptions, tariffs, and troublesome market conditions, regulatory scrutiny, and readiness challenges are some factors contributing to the IPO pause in India.
3. Companies like education loan provider Avanse Financial Services and contract drug maker Anthem Biosciences have postponed their IPO plans due to weak investor sentiment and global uncertainty.
4. Suraj Krishnaswamy, MD of Investment Banking at Axis Capital, explained that only select institutional investors are coming in given the global uncertainty and India-Pakistan tensions have not helped.
5. In the meantime, companies are focusing on private funding rounds, pre-IPO placements, and internal governance improvements while the conservative approach to capital raising may signal a focus on quality over quantity.
6. Optimism remains for the Indian IPO market as analysts anticipate a resurgence once market conditions stabilize, regulatory clarity improves, and investor confidence returns.
7. Companies that seize this period to strengthen their foundations are likely to benefit when the market picks up again in 2024, focusing on capital investments, valuation, and personal-finance strategies to ensure they are well-positioned for future business success.

Read also: